Review Article httpsdoiorg104070kcj20160429 Print ISSN 17385520 Online ISSN 17385555 Temporal Trends Hospitalized Patients Heart Failure Korea JongChan Youn MD Seongwoo Han MD KyuHyung Ryu MD Division Cardiology Dongtan Sacred Heart Hospital Hallym University College Medicine Hwaseong Korea Heart failure HF important cardiovascular disease increasing prevalence significant morbidity high mortality rapidly expanding health care costs The number HF patients increasing worldwide Korea exception Temporal trends representative Korean hospitalized HF registriesthe Hallym HF study Korean Multicenter HF study Korean Heart Failure KorHF registry Korean Acute Heart Failure KorAHF registry showed mild survival improvement reflecting overall HF patient care development Korea despite increased severity enrolled patients higher incidence multiple comorbidities Moreover device therapies implantable cardioverter defibrillator cardiac resynchronization therapy definitive treatment heart transplantation increasing Korea To prevent HF burden increase essential set long term effective prevention strategies better control ischemic heart disease hypertension diabetes risk factors HF development Moreover proper HF guidelines performance measures performance improvement programs necessary limit HF burden Korean Circ J 20174711624 KEY WORDS Heart failure Hospitalization Trends Korea Introduction Heart failure HF clinical syndrome characterized typical symptoms signs caused structural andor functional cardiac abnormalities1 HF important cardiovascular disease increasing prevalence significant morbidity high mortality rapidly expanding health care costs An HF diagnosis previously described malignant cancer given comparatively low 5year survival rates23 In 1991 5year mortality HF 11 higher corresponding rates gastrointestinal cancers A systematic review comparative 5year ageadjusted genderadjusted survival rates cancer Received December 5 2016 Revised December 8 2016 Accepted December 15 2016 Correspondence Seongwoo Han MD Division Cardiology Dongtan Sacred Heart Hospital Hallym University College Medicine Keunjaebonggil 7 Hwaseong 18450 Korea Tel 823180862530 Fax 823180862559 Email hansw29hallymorkr The authors financial conflicts This Open Access article distributed terms Creative Commons Attribution NonCommercial License httpcreativecommons orglicensesbync30 permits unrestricted noncommercial use distribution reproduction medium provided original work properly cited 16 stroke HF generally similar observed improvements survival diseases past decade34 The prevalence HF approximately 12 adult population developed countries rising 10 people 70 years age1 On basis data National Health Nutrition Examination Survey NHANES 20092012 57 million 22 people age 20 years HF 550000 people newly diagnosed HF year USA5 By 2030 prevalence HF increase 46 resulting 8 million people total medical costs HF patients expected increase 209 billion 531 billion56 In Japan estimated 10 million individuals HF number Japanese outpatients left ventricular LV dysfunction predicted gradually increase 979000 2005 13 million 20307 In Korea prevalence HF increased approximately times 075 2002 153 2013 expected increase 2fold 160 2015 335 2040 17 million Koreans expected HF89 Korean hospitalized heart failure registry Despite survival improvement chronic HF following introduction diseasemodifying treatments 1990s Copyright 2017 The Korean Society CardiologyKorean Circulation Journal 17 hospitalization acute heart failure AHF continues increase countries1014 AHF refers rapid HF onset worsening symptoms andor signs This lifethreatening medical condition requiring urgent evaluation treatment typically leading hospital admission1 Estimates clinical characteristics treatment prognosis temporal trends HF hospitalization central understanding healthcare utilization efforts improve patient care reduce health care costs Therefore aimed investigate temporal trends representative Korean hospitalized HF registriesthe Hallym HF study Korean Multicenter HF study KorHF registry KorAHF registry The Hallym HF study registry single university medical center 4 affiliated hospitalbased retrospective cohort study Korean hospitalized HF patients January 1987 December 1997 n165715 The Korean Multicenter HF study registry nationwide prospective observational multicenter registry 9 university hospitals hospitalized Korean HF patients January 1998 August 2003 n175916 The KorHF registry nationwide prospective observational multicenter registry 24 academic hospitals hospitalized Korean patients AHF June 2004 April 2009 n320017 The KorAHF registry nationwide prospective observational multicenter cohort registry 10 tertiary university hospitals hospitalized Korean patients AHF March 2011 March 2014 n562518 Concomitant progress Korean HF registries cornerstone Korean Society Heart Failure KSHF laid firmly publications1531 Since 2003 KSHF Koreas leading academic organization dedicated study heart failure KSHF promoted aspects research heart failure offered education health care professionals provided forums expertise experiences heart failure research treatment shared periodical conferences congresses symposiums In review article aimed evaluate temporal trends seen representative Korean HF registries focused patient population characteristics clinical status admission inhospital management clinical outcome Because long term prognosis KorAHF registry available analyzed KorAHF registry data published interim analysis results n206618 We briefly review temporal trend device therapies Korea implantable cardioverter defibrillators ICD cardiac resynchronization therapy CRT definitive treatment heart transplantation As shown Table 1 recent Korean HF registry patients older higher incidence comorbidities including hypertension diabetes atrial fibrillation stroke compared previous Korean HF registry populations Ischemic etiology associated higher proportion hospitalized HF patients hypertension HF etiology showed wide variation different registries Patients severe symptoms enrolled recent registry patients underwent echocardiography index admission period While mean value hemoglobin serum sodium creatinine comparable KorHF KorAHF registries proportion patients anemia hyponatremia azotemia increased data shown Regarding inhospital management frequent use intravenous diuretics inotropes vasodilators mechanical ventilation renal replacement therapy noted recent period reflecting increased HF severity patient population The prescription rate betablockers discharge lower KorAHF registry angiotensin converting enzyme inhibitor ACEiangiotensin receptor blocker ARB higher Despite increased HF severity enrolled patients recent registry showed mild improvement inhospital mortality indicating overall development hospitalized HF patient care Korea Age One outstanding findings comparisons Korean hospitalized HF registries rapidly increasing mean age patient population Fig 1 HF major causes death hospitalization elderly patients The Korean National Health Insurance Service NHIS sample cohort data showed prevalence HF 126 subjects aged 80 years older 10 55 aged 40 59 years 6079 years respectively The prevalence HF subjects aged 80 years older approximately 8fold higher overall prevalence HF 1538 Age important prognostic factor Hallym HF registry Korean Multicenter HF study registry KorHF registry well1517 The KorAHF registry showed old age 70 years independent predictor postdischarge mortality18 Data countries revealed overall number hospitalizations heart failure increased particularly aged population1113 With aging general population epidemiologic burden HF increase substantially Comorbidities Temporal trends hospitalized HF patient comorbidities showed increasing prevalence hypertension diabetes Fig 2 The Korean JongChan Youn et alhttpsdoiorg104070kcj20160429wwwekcjorg 18 Table 1 Comparison Korean hospitalized HF registry Time period January 1987December 1997 January 1998August 2003 June 2004April 2009 March 2011May 2012 Hallym HF study n1657 Korean multicenter HF study n1759 KorHF n3200 KorAHF n2066 No participating hospitals 4 Demographics Male Age year Hypertension Diabetes mellitus Atrial fibrillation Stroke Etiology Ischemic Hypertensive Cardiomyopathy Idiopathic dilated Valvular Inhospital management Intravenous inotropes IABP Mechanical ventilation Hemodialysis CRRT ECMOPCPS Medication discharge Betablocker ACEiARB Aldosterone antagonist Digitalis Total mean medical cost x 103 KRW Admission duration day 432 637134 404 199 92 95 293 267 255 153 172 651 ACEi 520 113122 Inhospital mortality 58 1 month mortality 6month cumulative survival 1year cumulative survival 874 820 9 529 641143 24 50 10 55 676143 6914 302 256 275 86 323 165 227 149 135 905 801 465 305 224 189 523 367 265 233 127 358 33 71 41 586 537 531 139 6658 9 64 850 59 36 27 15 38 6 21 15 13 400 39 140 45 43 25 440 650 404 7700 8 52 excluding HTx 908 Expressed median duration HF heart failure KorHF Korean heart failure KorAHF Korean acute heart failure IABP intraaortic balloon pump CRRT continuous renal replacement therapy ECMO extracorporeal membrane oxygenation PCPS percutaneous cardiopulmonary support ACEi angiotensin converting enzymeinhibitor ARB angiotensin receptor blocker KRW Korean won HTx heart transplantation NHIS sample cohort data revealed hypertension diabetes common HF patients The prevalence hypertension comorbidity hospitalized HF patients remained high diabetes markedly increasing 2013 compared 2003 hypertension 462 diabetes 334 2003 hypertension 436 diabetes 491 2013 respectively8 Data Western Australia revealed hypertension diabetes predominant comorbidities associated HF prevalence risk factors HF including hypertension diabetes renal failure atrial fibrillation increased 1990 2005 Temporal Trends Hospitalized Heart Failure Koreahttpsdoiorg104070kcj20160429wwwekcjorg 19 690 676 637 641 r e y e g A 70 68 66 64 62 60 Ischemic Hypertensive Cardiomyopathy Valvular 323 293 267255 172 165 227 135 523 367 380 265 127 210 130 60 e g t n e c r e P 60 50 40 30 20 10 0 Hallym HF study 19871997 Korean multicenter HF study 19982003 KorHF registry 20042009 KorAHF registry 20112012 Hallym HF study 19871997 Korean multicenter HF study 19982003 KorHF registry 20042009 KorAHF registry 20112012 Fig 1 Temporal trends mean age Korean hospitalized HF registry HF Heart failure KorHF Korean heart failure KorAHF Korean acute heart failure Fig 3 Temporal trends etiologies Korean hospitalized HF registry HF heart failure KorHF Korean heart failure KorAHF Korean acute heart failure Hypertension Diabetes 590 404 199 302 256 465 305 360 e g t n e c r e P 70 60 50 40 30 20 10 0 Hallym HF study 19871997 Korean multicenter HF study 19982003 KorHF registry 20042009 KorAHF registry 20112012 Fig 2 Temporal trends comorbidities Korean hospitalized HF registry HF heart failure KorHF Korean heart failure KorAHF Korean acute heart failure Asia including China Japan78 Cardiomyopathy valvular heart disease etiologies underlying HF hospitalization showed consistent proportions different time periods hypertension HF etiology showed wide variation different registries Hypertension HF etiology significantly lower KorAHF registry compared registries This result different initial evaluation protocols KorAHF registry limited number participating tertiary hospitals higher rates hypertension awareness diagnosis control18 It difficult differentiate hypertension merely accompanying disease HF hospitalization etiology It necessary clearly define hypertensive heart failure uncontrolled hypertension clinical presentation result decompensation absence identifiable causes aging population demographics provided note caution respect future population trends HF11 Clinical outcomes prognostic factors Heart failure etiologies Ischemic etiology responsible high proportion hospitalized HF cases suggesting need better control ischemic heart disease order reduce HF hospitalization Fig 3 The number ischemic heart disease patients increased accelerated westernization lifestyle Korean people number survivors acute coronary syndrome dramatically increased development interventional medical progress general cardiovascular treatment Recently similar trends showing ischemia chief cause HF observed Even time point survival analysis showed variation different registries clinical outcomes showed mild improvement despite increased HF severity enrolled patients reflecting overall development HF patient care Korea Fig 4 Inhospital mortality 58 comparable registries The cumulative KaplanMeier estimates survival 3 available previous registry data sets showed modest improvement long term survival Fig 5 For proper analysis long term clinical outcomes detailed analysis propensity score matching necessary However common temporal trends clinical outcomes mild limited improvement irrespective medical surgical care JongChan Youn et alhttpsdoiorg104070kcj20160429wwwekcjorg 20 100 e t r l v v r u s 90 80 70 60 50 40 30 20 10 0 Discharge survival 6month survival 1year survival 2year survival 942 874 82 905 936 948 908 801 764 85 79 10 09 08 07 06 05 l v v r u s e v t l u m u C 0 0 KorHF study 20042009 Korean multicenter HF study 19982003 Hallym HF study 19871997 6 12 18 24 Hallym HF study 19871997 Korean multicenter HF study 19982003 KorHF registry 20042009 KorAHF registry 20112012 Time month Fig 4 Temporal trends clinical outcome Korean hospitalized HF registry HF heart failure KorHF Korean heart failure KorAHF Korean acute heart failure Fig 5 Cumulative KaplanMeier estimates survival according different time periods Korean hospitalized HF registry KorHF Korean heart failure HF heart failure development HF increased HF severity seen enrolled patients3233 Independent prognostic factors representative Korean hospitalized HF registries summarized Table 2 Hyponatremia independent predictor poor prognosis Hallym HF registry KorHF registry KorAHF registry Asian hospitalized HF registries1517183435 Data KorHF registry revealed hyponatremia admission associated higher allcause mortality irrespective hyponatremia improved hospitalization20 A multivariate regression analysis KorAHF registry data showed hyponatremia admission independent predictor hospital mortality postdischarge mortality18 Anemia wellknown prognostic factor patients HF commonly observed hospitalized HF patients The KorHF registry showed anemia admission independent predictor cause mortality hospitalized HF patients17 Renal dysfunction important findings hospitalization prognostic factor hospitalized HF patients The KorHF registry revealed renal dysfunction associated poor clinical outcomes17 A multivariate regression analysis KorAHF registry data showed renal dysfunction admission important prognostic factors inhospital mortality postdischarge mortality18 The cumulative survival curves HF etiologies shown Fig 6 The Hallym HF study revealed HF caused ischemic heart disease associated poorest cumulative survival 805 6 months 302 5 years 184 10 years HF caused hypertensive heart disease predicted better survival 908 6 months 538 5 years 311 10 years15 These patterns consistent subsequent Korean multicenter HF study HF caused ischemic heart disease showed poorest cumulative survival 794 6 months 702 1 year 597 2 years HF caused valvular Table 2 Independent predictors clinical outcome Korean hospitalized HF registry Hallym HF study n1657 Hyponatremia Diabetes Stroke Smoking Interruption ACE inhibitors Korean multicenter HF study n1759 Previous MI Diabetes Stroke KorHF n3200 Old age Hyponatremia Previous HF Anemia High NTproBNP Betablocker discharge KorAHF n2066 Old age Hyponatremia Renal dysfunction HF aggravation renal failure HF heart failure KorHF Korean heart failure KorAHF Korean acute heart failure MI myocardial infarction ACE angiotensin converting enzyme NTproB NP Nterminal prohormone brain natriuretic peptide Temporal Trends Hospitalized Heart Failure Koreahttpsdoiorg104070kcj20160429wwwekcjorg Hallym HF study 19871997 Korean multicenter HF study 19982003 21 l v v r u s e v t l u m u C 10 09 08 07 06 05 04 03 02 01 0 VHD CMP HHD IHD IHD HHD l v v r u s e v t l u m u C 10 09 08 07 06 05 04 03 02 01 0 VHD CMP HHD IHD 0 2 4 6 8 10 0 1 2 3 4 5 Time years Time years Fig 6 Cumulative KaplanMeier estimates survival hospitalized patients heart failure according etiologies HF heart failure VHD valvular heart disease CMP cardiomyopathy HHD hypertensive heart disease IHD Ischemic heart disease heart disease associated better survival 926 6 months 910 1 year 892 2 years followed HF caused cardiomyopathy hypertensive heart disease16 However long term survival valvular heart disease patients Hallym HF study revealed poor prognosis 79 years index admission requiring close attention patients HF etiology highly variable patients comorbid pathologies result HF hospitalization Identification diverse pathologies diagnostic workup offer specific therapeutic opportunities1 important issues management hospitalized HF patients Interruption ACEi treatment independent prognostic factor Hallym HF registry betablocker prescription discharge showed better clinical outcomes KorHF registry When 1527 patients KorHF registry left ventricular systolic dysfunction survived hospitalization evaluated multivariate analysis revealed adherence ACE inhibitor treatment ARB use discharge significantly associated mortality readmission 60 days adherence beta blockers discharge mortality 1 year22 Inhospital management More frequent use intravenous diuretics inotropes vasodilators mechanical ventilation renal replacement therapy recent time period result fact patients severe symptoms multiple comorbidities enrolled recent registry The advance active interventional treatment mechanical ventilation renal replacement therapy percutaneous cardiopulmonary support PCPS related improved inhospital mortality AHF patients PCPS actively engaged acute care patients cardiogenic shock associated clinical outcome improvement Korea36 Guideline directed medical therapy performance measures Implantable cardioverter defibrillators cardiac resynchronization therapy Korea In Korea device therapy HF patients ICD CRT underutilized cultural proscriptions low HF awareness patients strict insurance coverage criteria However device therapy recently increased steadily shown Fig 7 To real world data risks benefits device therapy HF clarify unmet needs device therapy Korean HF patients necessary establish prospective nationwide HF device therapy registry near future JongChan Youn et alhttpsdoiorg104070kcj20160429wwwekcjorg 22 1200 1000 800 600 400 200 0 r e b m u n l u n n A ICD CRT 160 140 120 100 80 60 40 20 0 r e b m u n l u n n A 50 26 29 23 21 12 15 11 145 127 118 107 98 84 73 65 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Year Year Fig 7 Temporal trends implantable cardioverter defibrillator cardiac resynchronization therapy Korea ICD implantable cardioverter defibrillator CRT cardiac resynchronization therapy Fig 8 Temporal trends heart transplantation Korea Heart transplantation Korea In Korea heart transplantation performed Asan medical center 1992 The recipient 51 years old time alive 23 years By December 31st 2015 total 1136 heart transplants Korea37 Before 2000 annual heart transplants 20 transplants increased 50 2007 recently annual number 120 Fig 8 A nationwide heart transplant cohort study Korean Organ Transplant Registry KOTRY 2013 started In Korea unlike Asian countries religious social beliefs hinder organ donation number heart transplants increased steadily recent periods3738 However significant organ shortage organ donation increasing Korea rapidly increasing number endstage HF patients requiring definitive treatment Accordingly mechanical circulatory support devices particularly continuousflow left ventricular assist devices LVADs increas ingly seen alternative heart transplantation North Amer ica Europe The number patients permanent LVAD considered old ineligible transplanta tion constantly growing For majority patients lifelong LVAD therapy despite eligibility transplantation clinical reality1 However LVADs actively Korean endstage HF patients care government regulation insurance issues Future strategies reduce heart failure burden The prevalence hypertension diabetes ischemic heart disease important risk factors HF increasing58 Patients acute cardiovascular disease status survive longer development advanced medical surgical therapies accelerated aging general population result patients risk developing HF6 If increased HF burdens avoided prevention incident HF proper guidelines HF treatment essential Proper understanding risk factors HF important development preventive strategies Demographic risk factors development HF include older age male gender smoking obesity specific diseases ischemic heart disease hypertension diabetes contribute significantly development HF6 Ischemic heart disease important risk factors hospitalized HF Korea requires special monitoring program Hypertension associated smaller relative risk HF development associated ischemic heart disease contributes overall HF burden higher prevalence6 The prevalence diabetes comorbidity Korean hospitalized HF patients steadily increasing known diabetes insulin resistance obesity linked HF development To prevent increased HF burdens essential set long term effective preemptive prevention strategies better control ischemic heart disease hypertension diabetes risk factors HF development Not prevention treatment HF improved enhanced adherence guideline directed management6 In effort increase use evidencebased prevention treatment approaches KSHF produced Korean guidelines prevention treatment chronic HF 2015 AHF 2016 By facilitating measurements cardiovascular healthcare quality performance measures serve effective methods accelerate appropriate translation Temporal Trends Hospitalized Heart Failure Koreahttpsdoiorg104070kcj20160429wwwekcjorg 23 scientific evidence clinical practice6 Performance improvement programs facilitated implementation evidencebased therapies hospital ambulatory care settings known providing better levels care based performance measures associated better patient survival rates patients HF622 Therefore proper guidelines performance measures performance improvement programs substantial impact cardiovascular prevention treatment important tools limiting burden HF In summary temporal trends seen representative Korean HF registriesthe Hallym HF study Korean Multicenter HF study KorHF registry KorAHF registry showed mild improvement HF mortality reflecting overall development AHF patient care Korea despite increased disease severity enrolled patients including higher incidence multiple comorbidities To prevent increasing HF burdens essential set long term effective preemptive prevention strategies better control ischemic heart disease hypertension diabetes risk factors development HF Moreover proper HF guidelines performance measures performance improvement programs necessary limit HF burden Acknowledgements This study supported fund Korean Society Cardiology 20140303 Basic Science Research Program National Research Foundation Korea NRF funded Ministry Science ICT Future Planning NRF 2015R1C1A1A02036645 The funders role study design data collection analysis decision publish preparation manuscript The authors declared competing interests exist The authors express gratitude Korean representative heart failure physicians MyungMook Lee ByungHee Oh Shung Chull Chae MyeongChan Cho EunSeok Jeon JaeJoong Kim DongJu Choi SeokMin Kang ByungSu Yoo actively participated Korean hospitalized heart failure registry study References ESC Eur Heart J 2016372129200 2 Stewart S MacIntyre K Hole DJ Capewell S McMurray JJ More malignant cancer Fiveyear survival following admission heart failure Eur J Heart Fail 2001331522 3 Ziaeian B Fonarow GC Epidemiology aetiology heart failure Nat Rev Cardiol 20161336878 4 Askoxylakis V Thieke C Pleger ST et al Longterm survival cancer patients compared heart failure stroke systematic review BMC Cancer 201010105 5 Writing Group M Mozaffarian D Benjamin EJ et al Heart disease stroke statistics2016 update report American Heart Association Circulation 2016133e38360 6 Heidenreich PA Albert NM Allen LA et al Forecasting impact heart failure United States policy statement American Heart Association Circ Heart Fail 2013660619 7 Okura Y Ramadan MM Ohno Y et al Impending epidemic future projection heart failure Japan year 2055 Circ J 20087248991 8 Lee JH Lim NK Cho MC Park HY Epidemiology Heart Failure Korea Present Future Korean Circ J 20164665864 9 Park JJ Choi DJ Heart failure epidemic expected phenomenon Korean Circ J 2016466102 10 Fang J Mensah GA Croft JB Keenan NL Heart failurerelated hospitalization US 1979 2004 J Am Coll Cardiol 20085242834 11 Teng TH Finn J Hobbs M Hung J Heart failure incidence case fatality hospitalization rates Western Australia 1990 2005 Circ Heart Fail 2010323643 12 Filippatos G Farmakis D Bistola V et al Temporal trends epidemiology clinical presentation management acute heart failure results Greek cohorts Acute Heart Failure Global Registry Standard Treatment European Society CardiologyHeart Failure pilot survey Eur Heart J Acute Cardiovasc Care 2014 Epub ahead print doi 1011772048872614527012 13 Agarwal SK Wruck L Quibrera M et al Temporal Trends Hospitalization Acute Decompensated Heart Failure United States 19982011 Am J Epidemiol 201618346270 14 Kang SM Cho MC Prognostic Factors Hospitalization Heart Failure Asia Heart Fail Clin 20151154350 15 Lee Y Chinical characteristics korean patients congestive heart failure Korean J Med 19985544652 16 Han SW Ryu KH Chae SC et al Multicenter analysis clinical 1 Ponikowski P Voors AA Anker SD et al 2016 ESC Guidelines characteristics prognostic factors patients congestive diagnosis treatment acute chronic heart failure The Task heart failure Korea Korean Circ J 20053535761 Force diagnosis treatment acute chronic heart 17 Choi DJ Han S Jeon ES et al Characteristics outcomes failure European Society Cardiology ESC Developed predictors longterm mortality patients hospitalized acute special contribution Heart Failure Association HFA heart failure report korean heart failure registry Korean JongChan Youn et alhttpsdoiorg104070kcj20160429wwwekcjorg 24 Circ J 20114136371 inflammatory Nterminal probrain natriuretic peptide 18 Lee SE Cho HJ Lee HY et al A multicentre cohort study acute neurohumoral marker acute heart failure Korean Heart heart failure syndromes Korea rationale design interim Failure registry Am J Cardiol 20141135117 observations Korean Acute Heart Failure KorAHF registry Eur 28 Kang SH Park JJ Choi DJ et al Prognostic value NTproBNP heart J Heart Fail 2014167008 failure preserved versus reduced EF Heart 201510118818 19 Hong SJ Oh J Kang SM et al Clinical implication right bundle 29 Oh J Kang SM Song MK et al Clinical benefit spironolactone branch block hospitalized patients acute heart failure data patients acute decompensated heart failure severe renal Korean Heart Failure KorHF Registry Int J Cardiol dysfunction Data Korean Heart Failure Registry Am Heart J 20121574168 201516971320e3 20 Lee SE Choi DJ Yoon CH et al Improvement hyponatraemia 30 Park JJ Choi DJ Yoon CH et al The prognostic value arterial blood hospitalisation acute heart failure associated gas analysis highrisk acute heart failure patients analysis improvement prognosis analysis Korean Heart Failure Korean Heart Failure KorHF registry Eur J Heart Fail 20151760111 KorHF registry Heart 2012981798804 31 Ryu KH Han SW Clinical Characterisrics prognositic factors 21 Yoon CH Youn TJ Ahn S et al Low serum total cholesterol level patients congestive heart failure Korea epidemiology surrogate marker risk factor poor outcome patients congestive heart failure Korea J Korean Soc Hypertens 200283847 hospitalized acute heart failure report Korean Heart 32 Youn JC Seo SM Lee HS et al Trends hospitalized acute myocardial Failure Registry J Card Fail 201218194201 infarction patients heart failure Korea 1998 2008 J 22 Youn YJ Yoo BS Lee JW et al Treatment performance measures Korean Med Sci 2014295449 affect clinical outcomes patients acute systolic heart failure 33 Sato N Epidemiology Heart Failure Asia Heart Fail Clin report Korean Heart Failure Registry Circ J 20127611518 2015115739 23 Oh J Kang SM Hong N et al Hemoconcentration good 34 Bae MH Chae SC Hyponatremia acute heart failure marker prognostic predictor clinical outcomes acute heart failure data poor condition mediator poor outcome Korean J Intern Med Korean Heart Failure KorHF Registry Int J Cardiol 2015304502 2013168473943 35 Yoo BS Park JJ Choi DJ et al Prognostic value hyponatremia 24 Oh J Kang SM Hong N et al The CKDEPI accurate clinical heart failure patients analysis Clinical Characteristics outcome prediction MDRD equation acute heart failure data Outcomes Relation Serum Sodium Level Asian Patients Korean Heart Failure KorHF Registry Int J Cardiol Hospitalized Heart Failure COAST study Korean J Intern Med 201316710847 20153046070 25 Park HS Kim H Park JH et al QRS prolongation prediction 36 Shin TG Choi JH Jo IJ et al Extracorporeal cardiopulmonary clinical cardiac events patients acute heart failure analysis resuscitation patients inhospital cardiac arrest comparison data Korean Acute Heart Failure Registry Cardiology conventional cardiopulmonary resuscitation Crit Care Med 201312596103 20113917 26 Park SJ On YK Byeon K et al Short longterm outcomes 37 Korean Network Organ Sharing KONOS Official Web site depending electrical dyssynchrony markers patients presenting KONOS Internet c2016 cited 2016 July 1 Available https acute heart failure clinical implication firstdegree wwwkonosgokrkonosisindexjsp atrioventricular block QRS prolongation Korean Heart 38 Krittayaphong R Ariyachaipanich A Heart Transplant Asia Heart Failure registry Am Heart J 20131655764 e2 Fail Clin 20151156372 27 Park JJ Choi DJ Yoon CH et al Prognostic value Creactive protein Temporal Trends Hospitalized Heart Failure Koreahttpsdoiorg104070kcj20160429wwwekcjorg